KT-253
kymera therapeutics
['leukemia', '$ibb', '$kymr', '$xbi', 'kymera ']
$kymr $kt kymera therapeutics presents the superior efficacy of kt-253, a heterobifunctional mdm2 degrader, over small molecule inhibitor in preclinical leukemia models at the european hematology association congress. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt